ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 939 filers reported holding ASTRAZENECA PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,368 | -5.4% | 286 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $20,469 | +3.1% | 286 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,851 | +2.4% | 286 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $19,391 | +21.2% | 286 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -20.0% | 286 | -7.1% | 0.00% | -25.0% |
| Q2 2022 | $20,000 | 0.0% | 308 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | 0.0% | 308 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | +17.6% | 338 | +18.2% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +21.4% | 286 | +20.7% | 0.00% | +33.3% |
| Q2 2021 | $14,000 | +16.7% | 237 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | 0.0% | 237 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | -7.7% | 237 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $13,000 | -53.6% | 237 | -55.4% | 0.00% | -55.6% |
| Q2 2020 | $28,000 | +250.0% | 531 | +205.2% | 0.01% | +200.0% |
| Q1 2020 | $8,000 | +14.3% | 174 | +18.4% | 0.00% | -25.0% |
| Q4 2019 | $7,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |